Nature Biotechnology

Papers
(The H4-Index of Nature Biotechnology is 118. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Single-cell RNA-seq keeps cells alive2488
Fungal architecture is a thing, and it’s eye-catching1981
Fluorescence microscopy resolution increases to near-atomic level1455
Synthetic biologics provide a path to target bHLH transcription factors1300
AI’s plastic recycling859
Author Correction: LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding780
Integrating medicine, engineering and business to educate early-stage researchers in cardiovascular device development709
Cancer Moonshot aims at liquid biopsies692
People661
TRGT-ing the dark genome to accurately characterize tandem repeats at scale582
Denmark invests in mucosal vaccines559
Wireless microelectronic fibers to discover gut and brain pathways555
Overcoming unpredictability in biotech patents by tailored claiming aligned with genuine enablement535
Drug pipeline 1Q22 — a raft of new modalities … and clinical blowups523
Dreaming ideal protein structures426
Framework for predicting alloreactivity in hematopoietic cell transplants413
Bite-sized solutions391
Engineering innate immune cells for cancer immunotherapy386
Author Correction: An injectable bone marrow–like scaffold enhances T cell immunity after hematopoietic stem cell transplantation368
An optimized toolkit for prime editing368
A small and highly sensitive red/far-red optogenetic switch for applications in mammals366
Multi-omics single-cell data integration and regulatory inference with graph-linked embedding352
Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids350
Orchestration of secondary metabolite production in Streptomyces species342
Enhancing prime editing in hematopoietic stem and progenitor cells by modulating nucleotide metabolism332
Engineered serum markers for non-invasive monitoring of gene expression in the brain330
Democratizing knowledge representation with BioCypher321
The lysosomal degraders300
Dual SORT LNPs for multi-organ base editing297
Variant to function mapping at single-cell resolution through network propagation297
High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition292
In vivo development of immune tissue in human intestinal organoids transplanted into humanized mice280
Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome277
Reflective multi-immersion microscope objectives inspired by the Schmidt telescope276
People271
Author Correction: Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion262
Behind the graduate mental health crisis in science257
Cellular shuttles put mislocalized proteins in their right place254
Diffusion model expands RoseTTAFold’s power244
A competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites232
Biopharma dives into tumor-seeking radioactive drugs230
Chem-map profiles drug binding to chromatin in cells211
An oncolytic virus–T cell chimera for cancer immunotherapy211
Generative models for protein structures and sequences210
Automated reconstruction of whole-embryo cell lineages by learning from sparse annotations201
The world’s first CRISPR therapy is approved: who will receive it?200
Predicting transcriptional outcomes of novel multigene perturbations with GEARS197
Droplet-based transcriptome profiling of individual synapses196
Single-cell nanobody-based profiles of multiple epigenetic modalities and chromatin velocity195
Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy195
AI predicts cancer relapse from slides194
Biotech news from around the world190
Live cell imaging of signaling networks using a conventional microscope190
3Q22 — more malaise in the markets187
Light-sheet microscopy at high resolution186
The need for need-finding in medical education184
Author Correction: The cost of drug patent expiration date errors183
Biotech news from around the world179
People175
Gains in early-onset dementia with progranulin open new paths for drug discovery173
Who will oversee the ethical limits of human embryo research?172
HSV-1’s contribution as a vector for gene therapy172
Retraction Note: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN171
Slaughter-free meat hits the grocery shelf171
Next-generation psychedelics: should new agents skip the trip?171
Assessing workforce needs for the emerging CAR-T cell therapy industry170
Hallucinating functional protein sequences169
Cancer diagnostics169
Delix Therapeutics : psychedelics without the trip165
Towards the non-invasive imaging of brain networks and functions at high resolution163
Grand challenges in bioinformatics education and training162
Computationally designed enzymes show potent catalytic activity162
FDA approves first MASH drug162
Adrestia Therapeutics — Gene networks to the rescue160
Decoding gene regulation with CRISPR perturbations160
Nanotechnology offers alternative ways to fight COVID-19 pandemic with antivirals159
A language model beats alphafold2 on orphans159
Engineered phage with antibacterial CRISPR–Cas selectively reduce E. coli burden in mice156
Orna Therapeutics: circular logic156
Spatiotemporal multiplexed immunofluorescence imaging of living cells and tissues with bioorthogonal cycling of fluorescent probes155
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression154
Precise DNA cleavage using CRISPR-SpRYgests152
Delivering 3 billion doses of Comirnaty in 2021152
Prediction of peptide mass spectral libraries with machine learning151
Engineered pegRNAs improve prime editing efficiency151
Detection of mosaic and population-level structural variants with Sniffles2151
Large-scale discovery of chromatin dysregulation induced by oncofusions and other protein-coding variants150
A strategy to load, rethread and read protein sequences through a nanopore149
Drug pipeline 4Q22 — sticking around148
2022 – toughing out the trough148
Chemigenetic kinase biosensors illuminate cell signaling networks147
Improving non-viral knock-in with modified single-stranded DNAs and small molecules147
Top 20 translational researchers of 2020146
Baby’s first genome146
Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable145
A circularly permuted CasRx platform for efficient, site-specific RNA editing145
Biotech news from around the world144
100,000 whole-genome sequences’ diagnostic bonus141
Lab-made antibody stops malaria139
Forum: Boyden and Danzl139
Growth of biotech clusters over several decades through pioneering, variety and entrepreneurial science138
The devolution of biosimilars regulations138
Are ecological processes that select beneficial traits in agricultural microbes nature’s intellectual property rights?137
Control of mammalian gene expression by modulation of polyA signal cleavage at 5′ UTR136
COVID vaccine IP waiver agreed134
Synthetic virology: the experts speak132
Moderna feud with NIH over COVID vaccine132
Enzymatic synthesis of RNA oligonucleotides131
Consternation follows Marks’ FDA departure131
Prediction of prime editing insertion efficiencies using sequence features and DNA repair determinants129
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR128
Precision RNA base editing with engineered and endogenous effectors128
Microbiome-friendly phages join the campaign for better antimicrobials125
Data sharing in the age of deep learning124
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors124
Spatial host–microbiome sequencing reveals niches in the mouse gut123
Tension-tuned receptors for synthetic mechanotransduction and intercellular force detection122
CoSpar identifies early cell fate biases from single-cell transcriptomic and lineage information121
0.67291212081909